These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 17196413

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exhaled hydrogen sulfide in patients with chronic obstructive pulmonary disease and its correlation with exhaled nitric oxide.
    Sun Y, Wang XM, Chen YH, Zhu RX, Liao CC.
    Chin Med J (Engl); 2013; 126(17):3240-4. PubMed ID: 24033943
    [Abstract] [Full Text] [Related]

  • 4. Endogenous hydrogen sulfide in patients with COPD.
    Chen YH, Yao WZ, Geng B, Ding YL, Lu M, Zhao MW, Tang CS.
    Chest; 2005 Nov; 128(5):3205-11. PubMed ID: 16304263
    [Abstract] [Full Text] [Related]

  • 5. [Changes of leukotriene B4 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and the effects of theophylline].
    Ding YL, Yao WZ, Liu Z, Wang YZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):441-4. PubMed ID: 16115390
    [Abstract] [Full Text] [Related]

  • 6. [Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease].
    Chen YH, Yao WZ, Geng B, Ding YL, Lu M, Zhao MW, Tang CS.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):694-7. PubMed ID: 16255955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.
    Perng DW, Huang HY, Chen HM, Lee YC, Perng RP.
    Chest; 2004 Aug; 126(2):375-81. PubMed ID: 15302720
    [Abstract] [Full Text] [Related]

  • 9. Exhaled Hydrogen Sulfide Predicts Airway Inflammation Phenotype in COPD.
    Zhang J, Wang X, Chen Y, Yao W.
    Respir Care; 2015 Feb; 60(2):251-8. PubMed ID: 25336529
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.
    Profita M, Chiappara G, Mirabella F, Di Giorgi R, Chimenti L, Costanzo G, Riccobono L, Bellia V, Bousquet J, Vignola AM.
    Thorax; 2003 Jul; 58(7):573-9. PubMed ID: 12832668
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of low-dose theophylline on airway inflammation in COPD.
    Kobayashi M, Nasuhara Y, Betsuyaku T, Shibuya E, Tanino Y, Tanino M, Takamura K, Nagai K, Hosokawa T, Nishimura M.
    Respirology; 2004 Jun; 9(2):249-54. PubMed ID: 15182277
    [Abstract] [Full Text] [Related]

  • 16. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
    Zhang J, Yao WZ, Sun YC.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
    Grootendorst DC, Gauw SA, Benschop N, Sterk PJ, Hiemstra PS, Rabe KF.
    Pulm Pharmacol Ther; 2003 May; 16(6):341-7. PubMed ID: 14580925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.